Are you ready to elevate your von Hippel-Lindau disease management?

Dive into our Clinical Case Challenge and master the complexities of VHL disease care. [PRIME]( [Navigating the Nuances of von Hippel-Lindau (VHL) Disease Care: A Clinical Challenge in Treatment and Management]( [Take the CHALLENGE Today!]( Treatment and management of the rare disorder von Hippel-Lindau (VHL) disease is complicated due to the development of benign and malignant tumors and cysts in numerous organs/systems. Given the progressive nature of the disease and the development of disease manifestations over time, management often involves local control requiring a multidisciplinary approach. However, recently developed systemic therapies targeting the root cause of VHL disease provide an opportunity for effective management across numerous disease manifestations. Through this interactive Clinical Case Challenge, follow a real-world patient case, get instant feedback on answers to clinically relevant questions, and access downloadable evidence and relevant clinical practice tips. You can also see how you stack up against the knowledge of fellow healthcare providers! [0.25 CME/CE Credit Hour(s) | Clinical Case Study]( [For More Information Click Here]( [Take the CHALLENGE Today!]( Expert Faculty: Eric Jonasch, MD Speaker Professor of Medicine Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas, MD Anderson Cancer Center Director, VHL Clinical Center, MD Anderson Cancer Center Houston, Texas [Prime Education] PRIME Education, LLC 114 5th Ave, 14th Floor New York, NY 10011 (954) 718-6055 | [Contact us]( PRIME is a multi-disciplinary accredited provider of continuing medical education. [Unsubscribe from future emails](lst=NL_Prime_Specialty_Newsletters) | [Contact us]( | [COVID-19 Resource Center](